A PSMA-targeted Tri-specific Killer Engager enhances NK cell cytotoxicity against prostate cancer.

Autor: Phung SK; University of Minnesota, United States., Zorko NA; University of Minnesota, Minneapolis, Minnesota, United States., Soignier Y; University of Minnesota, Minneapolis, Minnesota, United States., Waller RL; University of Minnesota, Minneapolis, Minnesota, United States., Shackelford M; University of Minnesota, Minneapolis, Minnesota, United States., Walker JT; University of Minnesota, Minneapolis, Minnesota, United States., Nelson TD; University of Minnesota, Minneapolis, Minnesota, United States., Selleck C; University of Minnesota, Minneapolis, Minnesota, United States., Bendzick LE; University of Minnesota Twin Cities, Minneapolis, MN, United States., Kotz LE; University of Minnesota, Minneapolis, Minnesota, United States., Kile QM; University of Minnesota, Minneapolis, Minnesota, United States., Bozicevich AJ; University of Minnesota, Minneapolis, Minnesota, United States., Miller SE; University of Minnesota, Minneapolis, Minnesota, United States., Khaw M; University of Minnesota, United States., Shetty M; University of Minnesota, Minneapolis, MN, United States., Hinderlie P; University of Minnesota, Minneapolis, MN, United States., Ehrhardt M; University of Minnesota, Minneapolis, Minnesota, United States., Li Y; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States., Luo X; University of Minnesota, Minneapolis, MN, United States., Dehm SM; University of Minnesota, Minneapolis, MN, United States., Antonarakis ES; University of Minnesota, Minneapolis, United States., Kennedy PR; University of Minnesota, Minneapolis, Minnesota, United States., Miller JS; University of Minnesota, Minneapolis, MN, United States., Felices M; University of Minnesota, Minneapolis, Minnesota, United States.

Publikováno v: Cancer immunology research [Cancer Immunol Res] 2024 Nov 15. Date of Electronic Publication: 2024 Nov 15.